Skip to main content

Signal in the noise.

Pharma Leader Dr. Sherine Helmy to Share Insights at Free Business Development Event

Dr. Sherine Helmy, Chairman of Pharco Pharmaceuticals Group, is a prominent leader in the Egyptian and Arab pharmaceutical industry, bringing over 45 years of extensive experience.

1 min read
Pharma Leader Dr. Sherine Helmy to Share Insights at Free Business Development Event

Medhat Yassin, a business development and institutional transformation consultant, announced that prominent businessman Dr. Sherine Helmy will be joining a free meeting focused on business development essentials. This exciting event is scheduled for Saturday, June 27th, at the Greek Campus, running from 6:00 PM to 9:30 PM. Yassin shared on Facebook that Dr. Sherine Helmy's session will take place during the first hour of the event, from 6:00 PM to 7:00 PM. He'll deliver a talk on business development, followed by an open discussion where attendees can ask questions and get answers. He added that the meeting's activities will then continue with Mohamed Naji and Medhat Yassin. They'll lead specialized segments to explain key business development elements, and also welcome and discuss attendees' inquiries. Dr. Sherine Helmy currently serves as the Chairman of Pharco Pharmaceuticals Group. He's recognized as one of the most influential leaders in the Egyptian and Arab pharmaceutical industry, bringing over 45 years of extensive experience to the field. Dr. Helmy earned his Bachelor's degree in Pharmacy from Alexandria University. He also holds Master's and PhD degrees in Business Administration, along with a specialized certificate from Harvard Business School in negotiation and decision-making. Beyond his corporate role, he holds several academic, community, and advisory positions. He actively supports education, scientific research, and economic development in Egypt. Furthermore, he plays a significant role in advancing the pharmaceutical industry and boosting the standing of Egyptian companies both regionally and internationally.

Related editorial